Atlas Trials

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Clinical trial NCT04067960 · COMPLETED

Trial details

NCT number
NCT04067960
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Biliary Tract CarcinomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Brain NeoplasmMalignant Genitourinary System NeoplasmMalignant Solid NeoplasmPancreatobiliary Carcinoma
Start date
2019-06-06
Primary completion
2022-10-06
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.